Altria
MO
$66.09
-1.27%
Altria Group, Inc. is a leading U.S. tobacco company, operating through subsidiaries that produce cigarettes, smokeless tobacco, machine-made cigars, and innovative reduced-risk products such as nicotine pouches and e-vapor. With the iconic Marlboro brand commanding a 40% share of the U.S. cigarette market, Altria holds a dominant position in a mature but highly profitable industry, while also diversifying through stakes in Anheuser-Busch InBev and Cronos Group. The current investor narrative centers on the company's strategic pivot toward smoke-free alternatives, including the NJOY acquisition and the On! nicotine pouch line, as it navigates declining cigarette volumes and regulatory pressures. Recent headlines highlight a Q2 earnings miss and lowered guidance, which have sparked debate about the pace of its transformation and the sustainability of its high dividend yield.…
MO
Altria
$66.09
Related headlines
Investment Opinion: Should I buy MO Today?
Based on the analysis, I rate MO as a Hold. The stock offers a high dividend yield of 7.2% and a low forward PE of 11.2x, but the consensus analyst rating is 'hold' with an average target of $70, implying only 6.5% upside. The thesis is that MO is a stable income play with limited growth, suitable for income-focused investors but not for those seeking capital appreciation.
Sign up to view all
MO 12-Month Price Forecast
Altria's valuation is attractive, but the fundamental challenges of declining volumes and high payout ratio limit upside. The stock offers a high income yield, but capital appreciation is unlikely without a successful transformation. I would upgrade to bullish if smokeless products achieve significant scale and volumes stabilize, or downgrade to bearish if the dividend is cut or regulatory actions severely impact sales.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Altria's 12-month outlook, with a consensus price target around $70.00 and implied upside of +5.9% versus the current price.
Average Target
$70.00
0 analysts
Implied Upside
+5.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$58 - $82
Analyst target range
Altria is covered by 11 analysts, with a consensus recommendation of 'hold' and a mean rating of 2.64 (where 1 is strong buy and 5 is sell). The average price target is $70.00, implying an upside of 6.5% from the current price of $65.70. The distribution shows a mix of ratings, with recent actions from UBS (Buy), Barclays (Underweight), and Citigroup (Neutral), indicating a lack of strong conviction among analysts.
Bulls vs Bears: MO Investment Factors
Altria presents a classic value-income profile with a high dividend yield, low valuation, and strong margins, but faces secular decline in its core cigarette business. The bull case rests on the stock's cheapness and income appeal, while the bear case highlights volume declines and limited growth prospects. Currently, the bearish evidence is slightly stronger due to the Q2 earnings miss and negative relative strength, but the high dividend and low PE provide a floor. The key tension is whether Altria can successfully transition to smoke-free products fast enough to offset cigarette declines, which will determine if the stock re-rates higher or remains a value trap.
Bullish
- High Dividend Yield with Strong Payout: MO offers a dividend yield of 7.20%, well above the S&P 500 average of ~1.3%. The payout ratio is 100.2%, indicating the dividend is fully covered by earnings, providing a substantial income stream for investors.
- Attractive Valuation with Forward PE of 11.2x: The forward PE of 11.2x is significantly lower than the broader market (S&P 500 forward PE ~20x) and below its own trailing PE of 14.0x. This suggests the market is pricing in modest earnings growth, offering a potential value entry point.
- Strong Profitability with 72.2% Gross Margin: Altria maintains a gross margin of 72.2% and an operating margin of 59.8%, reflecting its pricing power and cost efficiency in a mature industry. These margins are among the highest in the consumer staples sector.
- Dominant Market Position with Marlboro at 40% Share: Marlboro holds a 40% share of the U.S. cigarette market, providing a durable competitive advantage. This brand strength supports consistent cash flows and pricing power, even as volumes decline.
Bearish
- Declining Cigarette Volumes: The company faces structural decline in cigarette volumes, with Q2 2026 earnings miss attributed to weaker volumes. This trend is expected to continue as health awareness and regulation reduce smoking rates, pressuring revenue growth.
- High Payout Ratio Limits Growth Investment: With a payout ratio of 100.2%, Altria distributes nearly all its earnings as dividends, leaving limited room for reinvestment in growth initiatives or debt reduction. This could constrain its ability to fund the smoke-free transition.
- Negative Relative Strength vs. Market: Over the past year, MO has underperformed the S&P 500 by 20.1 percentage points (relative strength -20.1%). This suggests persistent selling pressure and weak investor sentiment, which could continue.
- Analyst Consensus is Hold with Low Conviction: The consensus rating is 'hold' with a mean score of 2.64 (1=strong buy, 5=sell). The average price target of $70 implies only 6.5% upside, and recent actions include an Underweight from Barclays, indicating mixed sentiment.
MO Technical Analysis
Altria's stock has exhibited a broadly range-bound to slightly upward trend over the past year, with a 1-year price change of +22.88%, though it has recently pulled back from its highs. As of August 14, 2026, the stock trades at $65.70, which is 85.2% of its 52-week range (low of $54.70, high of $77.06), indicating it is closer to the lower end of its yearly band. This positioning suggests that while the stock has seen long-term appreciation, it is currently in a corrective phase, potentially offering a value entry point if the downtrend stabilizes.
Beta
0.49
0.49x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$55-$77
Price range past year
Annual Return
-2.3%
Cumulative gain past year
| Period | MO Return | S&P 500 |
|---|---|---|
| 1m | -8.4% | +2.5% |
| 3m | -10.6% | +2.7% |
| 6m | -2.2% | +11.1% |
| 1y | -2.3% | +20.5% |
| ytd | +15.3% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MO Fundamental Analysis
Altria's revenue trajectory shows a mixed but generally resilient picture, with the most recent quarter (Q1 2026) reporting revenue of $5.428 billion, a 20.12% year-over-year increase, driven largely by pricing power and growth in smokeless products. However, this growth is inconsistent, as Q4 2025 revenue was $5.846 billion, up from $5.106 billion in Q4 2024, but Q1 2025 revenue was only $4.519 billion, indicating volatility. The company's smokeable products segment remains the core, contributing $4.758 billion in Q1 2026, while smokeless products added $669 million, showing the ongoing shift toward reduced-risk alternatives.
Quarterly Revenue
$5.4B
2026-03
Revenue YoY Growth
+20.1%
YoY Comparison
Gross Margin
64.6%
Latest Quarter
Free Cash Flow
$8.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MO Overvalued?
Given Altria's positive net income, the price-to-earnings (PE) ratio is the most appropriate valuation metric. The trailing PE stands at 14.03x, while the forward PE is 11.20x, implying that the market expects earnings growth, which is consistent with the company's focus on cost efficiencies and smoke-free expansion. The gap between trailing and forward PE suggests a modest growth expectation, with the forward multiple being 20% lower, indicating that analysts anticipate improved profitability in the coming year.
PE
14.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a high payout ratio of 100.2%, leaving no retained earnings for growth or debt reduction. The company's debt-to-equity is negative (-7.34) due to negative equity, indicating significant leverage, though interest coverage appears adequate (operating income of $2.96B vs. interest expense of $258M in Q1 2026). Cash flow generation is strong (FCF TTM of $8.62B), but any earnings decline could threaten the dividend, which is a key investor attraction.